Tetanus neurotoxin could treat depression, Parkinson's, ALS
19 July, 2021A non-toxic derivative of the tetanus neurotoxin (Hc-TeTx) may serve to treat depression and neurodegenerative diseases, as demonstrated in animal models.
Treatment found to reverse dementia in mice
05 July, 2021The SAK3 molecule appeared to help improve memory and learning in a mouse model of Alzheimer's disease.
Edible cholera vaccine candidate made of powdered rice
01 July, 2021A new vaccine to protect against deadly cholera has been made by grinding up genetically modified grains of rice.
COVID-19 DNA vaccine trial commences Down Under
29 June, 2021Researchers are set to commence the first Phase 1 human trial of a COVID-19 gene-based DNA vaccine in Australia, delivered via a needle-free system.
Monash to manufacture mRNA COVID-19 vaccine for Phase 1 trials
22 June, 2021Monash University has received $5 million from the Victorian Government to manufacture the first Australian batch of a COVID-19 mRNA vaccine for clinical trials.
Novavax's Phase 3 vaccine trial yields promising results
17 June, 2021Novavax's COVID-19 vaccine demonstrated 100% protection against moderate and severe disease, with 90.4% efficacy overall, in the PREVENT-19 Phase 3 trial.
Researchers 'trick' stem cells into becoming bone
09 June, 2021Researchers have found a way to alter the shape and nucleus of individual stem cells, which could speed up recovery following bone replacements.
Hydrogel treats wounds, protects against bacteria
31 May, 2021A specially designed hydrogel prevents infections in wounds and works against all types of bacteria — including antibiotic-resistant ones.
Newly designed drug compound to stop malaria in its tracks
26 May, 2021Scientists have developed a set of compounds designed to stop the malaria parasite being able to burst out of red blood cells — a process vital to its replication and life cycle.
Australia secures 25 million Moderna vaccines
13 May, 2021The government has secured 25 million doses of the Moderna COVID-19 vaccine to further diversify its vaccine portfolio, as well as to provide access to a booster or variant vaccine.
Electrically activated glue used to seal broken blood vessels
07 May, 2021A new device offers a way to seal tears and holes in blood vessels, using an electrically activated glue patch applied via a minimally invasive balloon catheter.
Lab-created heart valves grow with the recipient
03 May, 2021If confirmed in humans, the new heart valves could prevent the need for repeated valve replacement surgeries in thousands of children each year.
Vic announces $50m for domestic mRNA vaccine manufacturing
22 April, 2021The Victorian Government will provide $50m to establish mRNA vaccine and therapeutic manufacturing in Melbourne — the first such capability in the Southern Hemisphere.
Statins could help save Tasmanian devils
21 April, 2021Cholesterol-lowering drugs could help delay the spread of the deadly Tasmanian devil facial tumour disease and may help protect the endangered Australian marsupials from extinction.
Why do breast cancer drugs stop working?
15 April, 2021Although breast cancer can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse. Researchers have now found out why this happens.
